ATLAS / Macro Radar / Reporting / AVTX

Avalo Therapeutics, Inc. (AVTX) reporting calendar

Avalo Therapeutics, Inc. files periodic reports with the SEC as AVTX on Nasdaq. Atlas tracks 38 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
20 Jul 2026 – 2 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
13 May 2026
Reports on record
38

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 42 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open AVTX market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202613 May 202643 days0001534120-26-000033
10-K31 Dec 202523 Mar 202682 days0001534120-26-000011
10-Q30 Sep 20256 Nov 202537 days0001534120-25-000018
10-Q30 Jun 20257 Aug 202538 days0001628280-25-038575
10-Q31 Mar 202512 May 202542 days0001628280-25-024436
10-K31 Dec 202420 Mar 202579 days0001628280-25-013986
10-Q30 Sep 20247 Nov 202438 days0001628280-24-045965
10-Q30 Jun 202412 Aug 202443 days0001628280-24-036591
10-Q31 Mar 202413 May 202443 days0001628280-24-022763
10-K31 Dec 202329 Mar 202489 days0001628280-24-013786
10-Q30 Sep 20239 Nov 202340 days0001628280-23-038036
10-Q30 Jun 20233 Aug 202334 days0001628280-23-026990
10-Q31 Mar 20234 May 202334 days0001628280-23-015703
10-K31 Dec 202229 Mar 202388 days0001628280-23-009630
10-Q30 Sep 20227 Nov 202238 days0001628280-22-028538
10-Q30 Jun 20224 Aug 202235 days0001628280-22-020866
10-Q31 Mar 20225 May 202235 days0001628280-22-012436
10-K31 Dec 20212 Mar 202261 days0001628280-22-004671
10-Q30 Sep 20219 Nov 202140 days0001628280-21-022546
10-Q30 Jun 20212 Aug 202133 days0001628280-21-015170
10-Q31 Mar 202113 May 202143 days0001628280-21-010083
10-K31 Dec 20208 Mar 202167 days0001628280-21-004162
10-Q30 Sep 20209 Nov 202040 days0001628280-20-016113
10-Q30 Jun 20206 Aug 202037 days0001628280-20-011892
10-Q31 Mar 20207 May 202037 days0001628280-20-006935
10-K31 Dec 201911 Mar 202071 days0001628280-20-003395
10-Q30 Sep 201914 Nov 201945 days0001628280-19-014207
10-Q30 Jun 20198 Aug 201939 days0001628280-19-010465
10-Q31 Mar 20199 May 201939 days0001628280-19-006439
10-K31 Dec 201818 Mar 201977 days0001628280-19-003078
10-Q30 Sep 201813 Nov 201844 days0001628280-18-014190
10-Q30 Jun 20189 Aug 201840 days0001628280-18-010858
10-Q31 Mar 201811 May 201841 days0001628280-18-006658
10-K31 Dec 20172 Apr 201892 days0001628280-18-003890
10-Q30 Sep 20177 Nov 201738 days0001628280-17-010968
10-Q30 Jun 201714 Aug 201745 days0001628280-17-008646
10-Q31 Mar 20179 May 201739 days0001628280-17-005206
10-K31 Dec 201614 Mar 201773 days0001628280-17-002566

Source: SEC EDGAR company submissions for CIK 0001534120. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.